Patent · US Active

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

US10590113B2 · kind B2 · utility

0Cited by

4References

10Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Zulan Pi · Pennington, US
Donna M. Bilder · Lambertville, US
Robert Paul Brigance · Levittown, US
Heather Finlay · Skillman, US
Wen Jiang · Shanghai, CN
James A. Johnson · Lawrenceville, US
R. Michael Lawrence · Yardley, US
Wei Meng · Pennington, US
Michael C. Myers · Newtown, US
Monique Phillips · Ewing, US
George O. Tora · Langhorne, US
Xiaojun Zhang · Hopewell, US

Key dates

Filing date	Sep 6, 2018
Grant date	Mar 17, 2020
Priority date	—
Expiry date	Sep 6, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.